TIGIT blockade restores T cell function in pancreatic cancer modelBy room34 / August 9, 2021 Blockade of CD155/TIGIT signaling in conjunction with PD-1 blockade and CD40 agonism restores T cell function in mouse pancreatic cancer model “The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer” Freed-Pastor WA, Tyler Jacks, et al. (July 2021) Cancer Cell S1535-6108(21)00384-6. doi: 10.1016/j.ccell.2021.07.007 Relevant Ancell Immunology tools anti-human TIGIT mAb Recombinant human TIGIT-muIg anti-human CD155 mAb (clone ANC6A3) anti-human CD155 mAb (clone ANC2B2) Recombinant human CD155-muIg
